In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the backbone of global medicinal production due to their widespread acceptance and patient familiarity. Moreover, the pharmaceutical industry boasts extensive expertise garnered over many decades in the intricate processes of designing, formulating, testing, manufacturing, and packaging solid dosage products. However, as the industry evolves, several technical challenges arise in the pursuit of optimizing tablet formulations for the future. Key hurdles include the implementation of patient-centric methodologies, addressing solubility and bioavailability concerns, and effectively transitioning parenteral products into solid dosage forms. These complexities necessitate focused research and innovation efforts to propel drug production into the next phase of advancement. Listen to industry experts to learn how the pharmaceutical industry is working towards building a better tablet to ensure its viability well into the future.
Brought to you by American Pharmaceutical Review, Pharmaceutical Outsourcing, and Tablets & Capsules.